This inventor holds 1 USPTO granted patent. Top assignee: Adaptimmune Limited. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Ellen Border: Innovator in T Cell Receptor Technology
Introduction
Ellen Border is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of immunology, particularly in the development of T cell receptors (TCRs). Her work focuses on enhancing the specificity and efficacy of TCRs for therapeutic applications.
Latest Patents
Ellen Border holds a patent related to T cell receptors that bind the HLA-A*02 restricted peptide GLYDGMEHL, derived from the MAGE-A10 protein. This invention demonstrates excellent specificity profiles for the MAGE epitope. The patent also includes nucleic acids encoding the TCRs, engineered cells presenting the TCRs, and pharmaceutical compositions comprising these innovative components.
Career Highlights
Ellen is associated with Adaptimmune Limited, a company dedicated to advancing T cell therapy. Her work has been instrumental in developing novel approaches to cancer treatment through targeted immunotherapy.
Collaborations
Ellen collaborates with notable colleagues, including Conor Hayes and Arsen Valeryevich Volkov, who contribute to her research and development efforts in the field of T cell receptors.
Conclusion
Ellen Border's innovative work in T cell receptor technology positions her as a key figure in the advancement of immunotherapy. Her contributions are paving the way for new therapeutic strategies in cancer treatment.